Pancreatic Islet Cell Transplantation Act of 2004
Latest Action
Became Public Law No: 108-362.
Official Summary
(This measure has not been amended since it was introduced. The expanded summary of the House passed version is repeated here.) Pancreatic Islet Cell Transplantation Act of 2004 - Amends the Public Health Service Act to allow pancreata procured for use in islet cell transplantation or research to be counted for certification purposes for qualified organ procurement organization grants. Requires the Diabetes Mellitus Interagency Coordinating Committee to include in its annual report an assessment of the Federal activities and programs related to pancreatic islet cell transplantation, which shall address: (1) the adequacy of funding; (2) policies and regulations affecting the supply of pancreata; (3) the effect of xenotransplantation; (4) the effect of the United Network for Organ Sharing policies; (5) the existing mechanisms to collect and coordinate outcome data from trials; (6) implementation of multi-agency clinical investigations; and (7) recommendations for legislation and administrative actions to increase the supply of pancreata.
GovScope Watchdog™
AI Government Intelligence™The Pancreatic Islet Cell Transplantation Act of 2004 amends the Public Health Service Act to allow pancreata used for islet cell transplantation or research to count toward certification for organ procurement organization grants. It also requires the Diabetes Mellitus Interagency Coordinating Committee to include an annual assessment of federal activities related to pancreatic islet cell transplantation, covering funding, policies, data collection, and recommendations to increase pancreata supply.
This bill updates certification criteria for organ procurement organizations and mandates federal reporting on pancreatic islet cell transplantation to support research and transplantation efforts.
- Allows pancreata procured for islet cell transplantation or research to be counted for certification of organ procurement organizations.
- Requires an annual report assessing federal programs, funding, policies, and data collection related to pancreatic islet cell transplantation.
- The report must include recommendations for legislation and administrative actions to increase the supply of pancreata.
Organ procurement organizations, researchers, and patients involved in pancreatic islet cell transplantation may benefit from improved certification processes and coordinated federal oversight.
The bill does not specify funding levels or mechanisms to implement the reporting requirements, which may affect execution. Coordination among multiple agencies and data collection could present administrative challenges.
This health-related bill originated in the House during the 108th Congress and has been enacted into law, indicating legislative agreement on addressing pancreatic islet cell transplantation issues.
No hidden impact flags detected
GovScope reviewed 11 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
The bill may improve coordination and data collection on pancreatic islet cell transplantation, potentially influencing future research, funding decisions, and organ supply policies.
The full bill text is not provided, limiting detailed analysis. Citizens may want to review the annual reports produced under this law to monitor federal activities and funding adequacy related to pancreatic islet cell transplantation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.